Bristol-Myers Squibb to buy Inhibitex for $2.5 billion
Pharmaceutical giant Bristol-Myers Squibb Company announced it was acquiring Inhibitex, Inc., a company specializing in treatment of hepatitis C, for $2.5 billion (1.9 billion euros).
Medications
Jan 08, 2012 |
not rated yet |
0
US approves India's Ranbaxy to make generic Lipitor
Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.
Medications
Dec 01, 2011 |
5 / 5 (1) |
0
Pharma giants open up drug patents in new collaboration
Pharmaceutical giants and the UN intellectual property agency launched Wednesday a collaboration to share certain patented drug information with public organisations.
Medications
Oct 26, 2011 |
5 / 5 (1) |
2
US approves new drug against skin cancer
A breakthrough drug that could extend survival in some patients with advanced skin cancer was approved on Wednesday by US regulators, offering the first new treatment for melanoma in 13 years.
Cancer
Aug 17, 2011 |
5 / 5 (1) |
0
Rutgers laboratory helped to create new HIV drug
Two decades after a Rutgers team began working with legendary drug developer Paul Janssen, founder of a Belgian subsidiary of pharmaceutical giant Johnson & Johnson in an effort to create new and potent drugs to fight AIDS, ...
HIV & AIDS
Jun 23, 2011 |
not rated yet |
0
- Pages: 1 2
